Baixar PDF

Outros usuários também visualizaram estes artigos

Outcomes after bone marrow versus peripheral blood haploidentical hematopoietic cell transplantation using post-transplant cyclophosphamide-based graft-versus-host disease prophylaxis Muhammad Kashif Amin; Moazzam Shahzad; Abat Khan; Valiko Begiashvili; Ushna Khan; Matthew McGuirk; Shaun DeJarnette; Sibgha Gull Chaudhary; Iqra Anwar; Nausheen Ahmed; Al-Ola Abdallah; Sunil H. Abhyankar; Joseph P. McGuirk; Anurag K. Singh; Muhammad Umair Mushtaq;
10.1016/j.htct.2025.106222
Long-term follow-up results of ruxolitinib as salvage therapy for chronic graft-versus-host disease Neslihan Mandaci Sanli; Esen Karaku¿;
Hematol Transfus Cell Ther. 2025;47:
A dream or reality: Consideration of `bloodless¿ hematopoietic stem cell transplants for Jehovah¿s witness patients Michael MacNeill; Adrienne Fulford; Deanna Caldwell; Uday Deotare;
Hematol Transfus Cell Ther. 2025;47: